Vaxcyte stockPCVX
Vaxcyte trades at $61.92, 31.8% below its 52-week high (Oct 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +34.2% year to date, +53.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for PCVX — after you log in
Open the terminalFrequently asked questions about Vaxcyte
What is the Vaxcyte stock price?
At the close on Nov 5, 2026: $61.92 (−5.72% on the day). 52-week high: $90.75 on Oct 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Vaxcyte report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed −28% year over year, revenue 0%.
Does Vaxcyte pay dividends?
No, Vaxcyte does not pay dividends.
Where does Vaxcyte trade and how to buy it?
Ticker PCVX, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Vaxcyte now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PCVX are in the terminal after you log in.